FAQ/Help |
Calendar |
Search |
Today's Posts |
|
Parkinson's Disease Clinical Trials For posting and discussion of clinical trials related to Parkinson's Disease, and for the Parkinson Pipeline Project. All are welcome. |
Reply |
|
Thread Tools | Display Modes |
|
07-30-2011, 05:22 AM | #1 | ||
|
|||
New Member
|
I agree with you concerning availability of this drug when the study ended. It seems unethical to give patients an improved medicine then "pull the rug from
underneath them" after the trial is over. Especially since the improvement was noticed the first time I took a dose. If Impax labs does not want to give us compassionate medicine, then at least let us have access to buy it with our neuro's prescription. But at least let us have that option, don't just drop us. IPX-066 pushed my dosaging back to what it was 6 years ago, 3X daily, as opposed to what i'm taking today, 5X a day. |
||
Reply With Quote |
07-30-2011, 08:21 AM | #2 | ||
|
|||
In Remembrance
|
Quote:
http://healthpolicyandreform.nejm.or...979&query=home
__________________
paula "Time is not neutral for those who have pd or for those who will get it." |
||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
YALE - A Different SPECT Scan Study is Open | Parkinson's Disease | |||
Teriflunomide: results of an open-label 144-week extension study | Multiple Sclerosis |